Akili announced that its board of directors approved an operating plan for 2023 that includes a 30% workforce reduction.
The Boston-based digital therapeutic developer’s reduction reaches across different areas and functions. In total, 30% of Akili’s workforce amounts to 46 employees. The company communicated the decision to employees on Jan. 12 and expects to complete the reduction by the end of the first quarter.
Get the full story at our sister site, Drug Delivery Business News.